financetom
Business
financetom
/
Business
/
OpenAI launches $50 million fund to support nonprofits, community organizations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI launches $50 million fund to support nonprofits, community organizations
Jul 18, 2025 12:11 PM

SAN FRANCISCO (Reuters) -ChatGPT maker OpenAI is launching a $50 million fund to support nonprofit and community organizations, the artificial intelligence company said on Friday.

The fund is the first action following a recommendations report from the San Francisco-based company's nonprofit commission, which was formed in April to guide OpenAI's philanthropic efforts.

OpenAI has been working to revamp its corporate structure, which it says is necessary in order to continue raising the massive amounts of capital needed to stay competitive in the AI arms race, a move it is trying to balance with its founding mission, as a nonprofit, to develop AI for the public good.

Currently, its nonprofit arm owns and controls its for-profit arm, and OpenAI plans to convert the for-profit entity into a public benefit corporation, of which the nonprofit parent would become a shareholder.

The nonprofit commission was established as part of OpenAI's efforts to show that it can remain true to its founding mission despite the corporate revamp. OpenAI said the fund will facilitate partnerships to implement AI in sectors such as education, economic opportunity, community organizing and healthcare. It will also back community-led research and innovation focused on using AI for public good.

The nonprofit commission submitted its recommendations report Thursday, following interviews with over 500 nonprofits and community experts. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moog Insider Sold Shares Worth $298,979, According to a Recent SEC Filing
Moog Insider Sold Shares Worth $298,979, According to a Recent SEC Filing
Nov 9, 2024
04:01 PM EST, 11/08/2024 (MT Newswires) -- Brian J Lipke, Director, on November 07, 2024, sold 1,343 shares in Moog ( MOG/A ) (MOGA, MOGB) for $298,979. Following the Form 4 filing with the SEC, Lipke has control over a total of 19,765 shares of the company, with 19,765 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/67887/000006788724000085/xslF345X05/wk-form4_1731099060.xml ...
Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing
Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing
Nov 9, 2024
04:23 PM EST, 11/08/2024 (MT Newswires) -- Giuseppe Ciaramella, President, on November 06, 2024, sold 51,110 shares in Beam Therapeutics ( BEAM ) for $1,347,050. Following the Form 4 filing with the SEC, Ciaramella has control over a total of 109,150 shares of the company, with 109,150 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1745999/000095017024124085/xslF345X05/ownership.xml ...
Enphase Energy to lay off 17% of workforce
Enphase Energy to lay off 17% of workforce
Nov 9, 2024
(Reuters) -Enphase Energy will cut its global workforce by about 17%, impacting about 500 employees and contractors, the solar inverter maker disclosed in a filing on Friday. Enphase will also streamline its operations by focusing contract manufacturing in four existing locations - two in the United States, one in India and one in China. The company will cease its contract...
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
Nov 9, 2024
04:53 PM EST, 11/08/2024 (MT Newswires) -- Fate Therapeutics ( FATE ) said late Friday that preclinical data for its CAR T-cell candidate FT836 demonstrated the product's potential for durable anti-tumor activity without intervention. The data support the pan-cancer activity of MICA/B targeting, and indicate that our next-generation, iPSC-derived CAR T-cell platform has the potential to drive potent and durable...
Copyright 2023-2026 - www.financetom.com All Rights Reserved